Page last updated: 2024-09-05

antiflammin p1 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

antiflammin p1 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 4 studies

Compound Research Comparison

Studies
(antiflammin p1)
Trials
(antiflammin p1)
Recent Studies (post-2010)
(antiflammin p1)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
23039,156187552

Protein Interaction Comparison

ProteinTaxonomyantiflammin p1 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baglioni, C; Bussolino, F; Camussi, G; Herrick-Davis, K; Tetta, C1
Baglioni, C; Camussi, G; Tetta, C1
Baglioni, C; Camussi, G; Tetta, C; Turello, E1
Filep, JG; Ouellet, S; Zouki, C1

Reviews

1 review(s) available for antiflammin p1 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Anti-inflammatory peptides inhibit synthesis of platelet-activating factor.
    Progress in clinical and biological research, 1990, Volume: 349

    Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Endopeptidases; Humans; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Peptides; Platelet Activating Factor; Protease Inhibitors; Tumor Necrosis Factor-alpha; Uteroglobin

1990

Other Studies

3 other study(ies) available for antiflammin p1 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:2

    Topics: Alanine; Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cells, Cultured; Enzyme Activation; Humans; Methionine; Molecular Sequence Data; Neutrophils; Norleucine; Oligopeptides; Peptide Fragments; Phagocytosis; Platelet Activating Factor; Rats; Uteroglobin

1991
Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions.
    Advances in experimental medicine and biology, 1990, Volume: 279

    Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; In Vitro Techniques; Macrophages; Molecular Sequence Data; Neutrophils; Oligopeptides; Peptide Fragments; Phospholipases A; Platelet Activating Factor; Rats; Uteroglobin

1990
The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2000, Volume: 14, Issue:3

    Topics: Adult; Annexin A1; Anti-Inflammatory Agents, Non-Steroidal; CD18 Antigens; Cell Adhesion; Cells, Cultured; Coronary Vessels; E-Selectin; Endothelium, Vascular; Gene Expression Regulation; Humans; In Vitro Techniques; Intercellular Adhesion Molecule-1; Kinetics; Leukocytes; Lymphocytes; Middle Aged; Monocytes; Neutrophils; Oligopeptides; Peptide Fragments; Platelet Activating Factor; Uteroglobin

2000